Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 6.39 is 16% below its 5-year average of 7.57, near the low end of its 5-year range (5.34–13.30).
As of the fiscal period ended Tuesday, June 30, 2026. 4.59% above its 12-month average of 6.11.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 6.39.
QUICK RATIO (ACID-TEST)
6.39
QUICK RATIO (ACID-TEST) AVG TTM
6.11
QUICK RATIO (ACID-TEST) AVG 3Y
6.97
QUICK RATIO (ACID-TEST) AVG 5Y
7.57
QUICK RATIO (ACID-TEST) AVG 10Y
6.65
QUICK RATIO (ACID-TEST) AVG 15Y
6.09
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+4.59%
CURRENT VS 3Y AVG
-8.34%
CURRENT VS 5Y AVG
-15.55%
CURRENT VS 10Y AVG
-3.83%
CURRENT VS 15Y AVG
+4.87%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+90.50%
vs the sector median at left
Market Cap
$1.81B
Quick Ratio (Acid-Test)
13.96
TTM Avg
11.13
3Y Avg
7.91
5Y Avg
6.39
Market Cap
$1.83B
Quick Ratio (Acid-Test)
2.62
TTM Avg
2.33
3Y Avg
2.98
5Y Avg
3.78
Market Cap
$1.83B
Quick Ratio (Acid-Test)
1.23
TTM Avg
1.57
3Y Avg
2.04
5Y Avg
2.44
Market Cap
$1.84B
Quick Ratio (Acid-Test)
21.18
TTM Avg
6.27
3Y Avg
4.65
5Y Avg
4.09
Market Cap
$1.77B
Quick Ratio (Acid-Test)
8.30
TTM Avg
3.78
3Y Avg
3.78
5Y Avg
3.78
Market Cap
$1.85B
Quick Ratio (Acid-Test)
15.08
TTM Avg
9.38
3Y Avg
7.12
5Y Avg
8.07
Market Cap
$1.75B
Quick Ratio (Acid-Test)
1.78
TTM Avg
1.68
3Y Avg
1.66
5Y Avg
1.61
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Xencor, Inc. (XNCR) | $1.81B | 6.39 | 6.11 | 6.97 | 7.57 |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.81B | 13.96 | 11.13 | 7.91 | 6.39 |
| Azenta, Inc. (AZTA)vs › | $1.81B | 2.21 | 3.08 | 5.65 | 4.53 |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.83B | 2.62 | 2.33 | 2.98 | 3.78 |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 1.23 | 1.57 | 2.04 | 2.44 |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.84B | 21.18 | 6.27 | 4.65 | 4.09 |
| Generate Biomedicines, Inc. (GENB)vs › | $1.77B | 8.30 | 3.78 | 3.78 | 3.78 |
| Immunome, Inc. (IMNM)vs › | $1.85B | 15.08 | 9.38 | 7.12 | 8.07 |
| Surgery Partners, Inc. (SGRY)vs › | $1.75B | 1.78 | 1.68 | 1.66 | 1.61 |
| Novavax, Inc. (NVAX)vs › | $1.86B | 2.30 | 1.54 | 1.10 | 1.25 |
Quick Ratio
6.39
Excludes inventory
Current Ratio
6.39
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 6.39 |
| 2026-03-31 | 6.57 |
| 2025-12-31 | 6.25 |
| 2025-09-30 | 5.99 |
| 2025-06-30 | 5.34 |
| 2025-03-31 | 5.89 |
| 2024-12-31 | 6.61 |
| 2024-09-30 | 6.23 |
| 2024-06-30 | 6.92 |
| 2024-03-31 | 8.09 |
| 2023-12-31 | 8.60 |
| 2023-09-30 | 10.77 |
| 2023-06-30 | 13.30 |
| 2023-03-31 | 9.68 |
| 2022-12-31 | 10.58 |
| 2022-09-30 | 7.42 |
| 2022-06-30 | 7.81 |
| 2022-03-31 | 8.30 |
| 2021-12-31 | 6.00 |
| 2021-09-30 | 7.44 |
| 2021-06-30 | 10.46 |
| 2021-03-31 | 5.92 |
| 2020-12-31 | 5.27 |
| 2020-09-30 | 8.10 |
| 2020-06-30 | 9.08 |
| 2020-03-31 | 8.92 |
| 2019-12-31 | 8.39 |
| 2019-09-30 | 8.92 |
| 2019-06-30 | 8.27 |
| 2019-03-31 | 6.66 |
| 2018-12-31 | 5.86 |
| 2018-09-30 | 5.51 |
| 2018-06-30 | 3.79 |
| 2018-03-31 | 6.41 |
| 2017-12-31 | 2.28 |
| 2017-09-30 | 2.17 |
| 2017-06-30 | 1.96 |
| 2017-03-31 | 1.55 |
| 2016-12-31 | 1.33 |
| 2016-09-30 | 1.00 |
| 2016-06-30 | 2.10 |
| 2016-03-31 | 2.77 |
| 2015-12-31 | 2.25 |
| 2015-09-30 | 2.31 |
| 2015-06-30 | 8.29 |
| 2015-03-31 | 21.15 |
| 2014-12-31 | 9.80 |
| 2014-09-30 | 6.15 |
| 2014-06-30 | 11.22 |
| 2014-03-31 | 10.72 |
| 2013-12-31 | 10.45 |
| 2013-09-30 | 1.25 |
| 2013-06-30 | 1.68 |
| 2013-03-31 | 0.00 |
| 2012-12-31 | 0.11 |
| 2012-09-30 | 0.00 |
